Food, Drugs, Healthcare, Life Sciences

US medical malpractice data reveals emerging healthcare liability trends that consistently appear in America before reaching the UK, offering insurers and indemnifiers critical early warning signals. With the gap between US and UK trends narrowing, particularly in areas like aesthetics and GLP-1 weight-loss medications, understanding these patterns becomes essential for identifying and managing risks before they mature into significant liability exposures.

The UK Patents Court has upheld the validity of Novartis' patent and SPC protecting Entresto, its blockbuster heart failure treatment combining valsartan and sacubitril.

The Advertising Standards Authority has banned a Yo! Sushi Instagram advertisement for violating new regulations on less healthy food marketing. The paid post promoted a limited-edition Chocolate Cream Puff made with KitKat, which falls under HFSS (high fat, salt, or sugar) food categories subject to stricter advertising rules that came into force in January.

The European Parliament and Council have agreed on the most significant reform of EU pharmaceutical legislation in two decades, fundamentally restructuring the regulatory data exclusivity and market protection framework for newly approved medicines. While the baseline eight-year data protection period remains unchanged, the market exclusivity system has been overhauled with a new modulated approach that reduces automatic protection and requires pharmaceutical companies to complete specific clinical studies

Geopolitical conflicts and climate change are threatening global food security by disrupting fertiliser supply chains and driving up costs. European companies are developing innovative solutions ranging from green ammonia production and nitrogen fixation technologies to circular fertilisers derived from waste streams and biological alternatives that enhance nutrient efficiency.

Glasgow's XWORKS innovation hub represents a £11 million investment in advanced manufacturing infrastructure, set to provide 45,000 sq ft of flexible workspace for mid-tech companies in clean energy, defence, space and life sciences sectors. The facility, scheduled for completion in early 2027, aims to lift technological limitations for innovators and start-ups while strengthening Glasgow's position as a destination for innovation-led businesses.

The British Medical Association has issued comprehensive guidance addressing the complex legal and ethical considerations healthcare professionals face when patients with mental capacity choose to voluntarily stop eating and drinking to hasten death. This guidance provides a structured framework for decision-making, care planning, and symptom management in these challenging clinical situations.

Kernicterus is a rare but serious brain injury that can occur when newborn jaundice is not properly monitored or treated. Understanding the risk factors - from premature birth and blood group incompatibility to early-onset jaundice and feeding difficulties - is crucial for parents and healthcare professionals to prevent this devastating condition through timely intervention.

A recent investigation has uncovered serious allegations of patient safety failures at the Northern Care Alliance NHS Foundation Trust, including claims of inadequate incident reporting, suppressed whistleblowing, and systemic governance problems. Staff describe patients allegedly dying in overcrowded emergency departments, delayed diagnoses, and concerns that serious incidents are being downgraded or closed without proper investigation.